跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 158,682 条关于
“THR - β”
全部
158,682
临床试验
154,032
药物
1,140
机构
620
资讯
2,890
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
去年
CDSCO Panel Rejects Phase III Trial Waivers for Resmetirom in India, Approves Bioequivalence Studies
29天前
CureGene Doses First Participant in Phase I Trial of Oral Liver-Targeting THR-β Agonist CG-0416
去年
FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis
11个月前
Eccogene Receives FDA Clearance for Phase 2a MOSAIC Trial Testing Dual-Target MASH Therapy
10个月前
CureGene's CG-0416 Shows Superior Fat Loss While Preserving Muscle in Preclinical Obesity Studies
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
去年
NASH Treatment Market to Reach Significant Growth by 2032, Driven by Emerging Therapies
去年
Rezdiffra Demonstrates Improved Quality of Life in NASH Patients with Fibrosis
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Advancement of NASH Cirrhosis Study
第 1 页,共 289 页
上一页
下一页